May 24, 2016 11:50 AM ET

Pharmaceuticals

Company Overview of ProCertus BioPharm, Inc.

Key Executives for ProCertus BioPharm, Inc.

NameBoard RelationshipsTitleAge
Paul M. K. Weiss Ph.D., MBA54 RelationshipsActing Chief Executive Officer, Acting President and Director58
William E. Fahl 13 RelationshipsFounder, Chairman and Chief Scientific Officer--
Todd G. Argall CPANo RelationshipsVice President of Finance--
Allen L. Thunberg No RelationshipsVice President of Development--

ProCertus BioPharm, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
William E. Fahl 13 RelationshipsProCertus BioPharm, Inc.--
Paul M. K. Weiss Ph.D., MBA 54 RelationshipsProCertus BioPharm, Inc.58
Robert Lippert 24 RelationshipsAtterx BioTherapeutics, Inc.58
Joseph V. Gulfo M.D., M.B.A. 13 RelationshipsProCertus BioPharm, Inc.52
Norman D. Weiner Ph.D. 23 RelationshipsProCertus BioPharm, Inc.--
View All Board Members

ProCertus BioPharm, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
388.3K
Bonus
551.1K
Total Short Term Compensation
582.6K
Total Value of Options
15.2M
Compensation as of Fiscal Year
ProCertus BioPharm, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

ANI Pharmaceuticals, Inc. Appoints Mark Ginski as Vice President Corticotropin Product Development
May 23, 2016 1:30 PM ET
Orexigen Therapeutics, Inc. Announces Executive Changes
May 23, 2016 1:30 PM ET
Sanofi Announces Executive Changes
May 23, 2016 1:19 PM ET
Casper Pharma Announces Executive Appointments
May 23, 2016 1:00 PM ET
Hybio Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year of 2015; Announces Management Changes
May 23, 2016 10:10 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ProCertus BioPharm, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.